Risk-based Regulation Proposed for DTC Genetic Tests | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – Since premarket studies are not likely to fully answer questions about the safety and effectiveness of genetic tests, those that are sold directly to consumers should be regulated through a system that incorporates risk-stratification and post-market surveillance, according to a new policy opinion proposal published today in Science.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.